StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Pfizer (PFE) Presents Initial Clinical Data on Phase 1b Gene Therapy Study for DMD
June 28, 2019 10:16 AM
Pfizer Inc. (NYSE: PFE) will present initial Phase 1b clinical data on PF-06939926, an investigational gene therapy to potentially treat ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
FDA
Hot Corp. News
Hot FDA News
Management Comments
Trader Talk
Next Articles
Pfizer (PFE) Reports Positive Top-Line Results from Phase 4 Study of Crisaborole Ointment
July 1, 2019 8:04 AM
Sarepta Therapeutics (SRPT) PT Raised to $220 at RBC Capital; Emrges as Clear Leader in DMD
July 1, 2019 6:18 AM
Buy Sarepta Therapeutics (SRPT) Strength as Pfizer Data Remove Overhang - Bloomberg, Citing RBC
June 28, 2019 11:06 AM
Sarepta Therapeutics (SRPT) Hits High, Up 20% Following Pfizer's DMD Results
June 28, 2019 10:26 AM
Pfizer Presents Initial Clinical Data on Phase 1b Gene Therapy Study for Duchenne Muscular Dystrophy (DMD)
June 28, 2019 10:15 AM
Pfizer (PFE) DMD Trial Pauses After One Child Hospitalized - Bloomberg
June 28, 2019 10:13 AM
